Welcome to our dedicated page for Sonendo news (Ticker: SONX), a resource for investors and traders seeking the latest updates and insights on Sonendo stock.
News for Sonendo, Inc. (SONX) centers on its activities as a commercial-stage medical technology and dental technology company. Sonendo develops and manufactures the GentleWave System, a platform for treating tooth decay and performing root canal therapy by cleaning and disinfecting microscopic spaces within teeth without removing tooth structure. Company news often reiterates this focus on saving teeth from tooth decay and improving clinical outcomes in endodontic care.
Investors and dental professionals following Sonendo’s news can expect regular updates on financial performance, including revenue from GentleWave consoles, procedure instruments and other products, as well as disclosures on gross margin, operating loss, adjusted EBITDA loss and free cash flow burn. The company has reported on a strategic reset and restructuring efforts aimed at stabilizing revenue, expanding margins and reducing operating expenses and cash burn.
Sonendo’s news flow also covers product and technology developments, such as the launch of ProControl for the GentleWave G4 System. This software update is described as enabling optimized cleaning of complex anatomy, increased procedure efficiency and the ability to adjust procedure fluid concentration levels when using the CleanFlow procedure instrument. Such announcements highlight the company’s focus on evolving its GentleWave platform and supporting personalized treatment in endodontics.
Additional news items may include capital-raising and financing transactions, such as private placements of common stock and amendments to credit facilities, as well as strategic transactions like the Asset Purchase Agreement to acquire Biolase assets through a bankruptcy court process and updates on related patent litigation. Leadership and organizational updates, including changes in operational roles, also appear in Sonendo’s press releases. For a consolidated view of these developments, this news page aggregates Sonendo’s public announcements and market-facing communications.
Sonendo, Inc. (OTCQX: SONX) reported its Q2 2024 financial results, showing promising signs of recovery. The company generated $8.3 million in total revenue, a slight 5% decrease from Q2 2023. However, GentleWave console revenue increased by 9% to $2.4 million. Notably, GAAP gross margin improved significantly to 37.5% from a negative 5.5% in Q2 2023, while adjusted gross margin reached 40.7%. The company also reduced its GAAP operating loss by 61% to $6.7 million and its adjusted EBITDA loss by 55% to $5.7 million. Based on these improvements, Sonendo has raised its 2024 full-year revenue guidance to $31-$32 million, up from the previous $29-$31 million range.
Sonendo, a dental technology company, will report its second quarter 2024 financial results on August 7, 2024, after market close. The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET the same day to discuss the results.
Interested investors can join the call by dialing (833) 470-1428 (domestic) or (404) 975-4839 (international) with the access code 699662. Live audio and an archived recording of the webcast will be available on the company's investor relations website, with the replay accessible for at least 30 days post-event.
Sonendo (OTCQX: SONX), a dental technology company known for its GentleWave® System, has announced key leadership changes. John Bostjancic has been appointed as Chief Financial Officer, Robert Guyatt as Senior Vice President of Marketing, and John McGaugh has been promoted to Senior Vice President of Operations. CEO Bjarne Bergheim stated that these appointments are part of a 'reset strategy' aimed at enhancing commercial execution, margin expansion, and cash conservation. These leadership changes are expected to drive significant growth and operational improvements for Sonendo.
Sonendo, a prominent dental technology company and creator of the GentleWave® System, will participate in the 2024 Stifel Jaws & Paws Conference. This event is scheduled for May 29th, with Sonendo's management presenting at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time. Investors and interested parties can access an audio webcast of the presentation through the company's website. This participation underscores Sonendo's commitment to engaging with the investor community and showcasing its innovative dental solutions.
Sonendo, Inc. reported total revenue of $7.0 million for Q1 2024, surpassing guidance. They achieved a healthy console backlog, raised average procedure instrument selling price, and divested TDO software segment. The company announced a strategic reset focusing on commercial strategy, cash conservation, and margin expansion. Despite a GAAP operating loss of $10.2 million, non-GAAP operating loss improved. Sonendo raised their 2024 revenue guidance range to $29-$31 million.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.